Emcure Pharmaceuticals IPO: 8 key things to know before subscribing to the issue
![Emcure Pharmaceuticals IPO includes a fresh issuance of equity shares worth ₹800 crore, along with an OFS by promoters and current shareholders totaling 1.14 crore equity shares valued at ₹1,152 crore, at the upper price range. Emcure Pharmaceuticals IPO includes a fresh issuance of equity shares worth ₹800 crore, along with an OFS by promoters and current shareholders totaling 1.14 crore equity shares valued at ₹1,152 crore, at the upper price range.](https://www.livemint.com/lm-img/img/2024/07/03/original/IPO_RELEASE_1720004716457.jpg)
Emcure Pharmaceuticals' IPO has commenced with anchor investors contributing ₹582 crore. The price range for shares is set between ₹960 and ₹1,008. The IPO will conclude on July 5, with allocation percentages designated for various investor categories.